01—Abstract
Summary
Summary of the 8-K filed June 3, 2024. Cited figures are marked; the original filing is the authoritative source.
Medtronic plc, through its indirect wholly owned subsidiary Medtronic, Inc., has successfully completed a significant debt offering, raising approximately €2.97 billion.
This offering comprises four series of senior notes due in 2029, 2036, 2043, and 2053, with coupon rates ranging from 3.650%a to 4.150%. These notes are fully guaranteed by Medtronic Global Holdings S.C.A. and Medtronic plc, providing an additional layer of credit support for investors. The net proceeds are intended for general corporate purposes, including the potential repayment of outstanding commercial paper and other existing indebtedness.
This strategic move suggests Medtronic is actively managing its capital structure and may be refinancing existing debt, potentially at more favorable terms or extending its debt maturity profile. The company has applied to list these new notes on the New York Stock Exchange, enhancing their liquidity and accessibility for investors.
02—Key points
Key Highlights
- Medtronic plc subsidiary issued €2.97 billion in senior notes across four maturity dates (2029, 2036, 2043, 2053).
- The offering includes fixed coupon rates from 3.650% to 4.150%.
- The notes are fully and unconditionally guaranteed by Medtronic Global Holdings S.C.A. and Medtronic plc.
- Proceeds will be used for general corporate purposes, including potential repayment of commercial paper and other debt.
- The company has applied to list the notes on the New York Stock Exchange for enhanced liquidity.
- The debt issuance was established under a comprehensive indenture and agency agreement framework, with specific supplemental indentures executed for this offering.
03—Questions
Frequently Asked Questions
What is the total amount of debt Medtronic plc raised in this offering?
Medtronic plc, through its subsidiary Medtronic, Inc., raised approximately €2.97 billion in aggregate principal amount from the offering of its senior notes.
What will Medtronic plc use the proceeds from this debt offering for?
The net proceeds are intended for general corporate purposes, which may include the repayment of outstanding commercial paper and other indebtedness.
Are the newly issued notes secured or unsecured?
The notes are general unsecured senior obligations of Medtronic, Inc. and will rank equally with Medtronic, Inc.'s other existing and future unsecured senior indebtedness. They are structurally subordinated to obligations of subsidiaries other than Medtronic Luxco and Medtronic, Inc.
Will these new notes be publicly traded?
Yes, Medtronic plc has applied to list each series of the notes on the New York Stock Exchange.
04—Continue